Global Blood Plasma Market: Industry Analysis & Outlook (2017-2021)


#1066785

83pages

Koncept Analytics

$ 800

In Stock

Plasma is obtained from blood after separation from red blood cells, white blood cells and platelets. The major components of blood plasma include proteins, amino acids, and other essential nutrients. Among these, proteins form the most important part of plasma and constitutes albumin, immunoglobulin, factor VIII, factor IX, alpha1 and many more. Plasma proteins are extracted from blood and used for many therapeutic indications.
 
Blood plasma is important because they fight off foreign substances that invade the body and transport nutrients and water. Plasma and recovered plasma are used to produce therapies that treat people with rare, chronic diseases and disorders such as primary immunodeficiency, hemophilia and genetic lung disease, as well as in the treatment of trauma, burns and shock. North America is the largest market for blood plasma as it has the most advanced infrastructure which has helped in increasing plasma collections over the time.
 
Growth factors of the global blood plasma market include increased diagnosis rate, rise in plasma collections and robust growth in emerging economies. Major trends of the market include increase in fractionation capacity, growing AATD market potential, and innovation in therapeutics. The market growth is hindered by factors such as high cost of treatment, lengthy approval process and high R&D costs.
 
The report offers an in-depth analysis of the global blood plasma market. It also covers global as well as regional aspect of the market. The report profiles the top notch players of the market including Shire Plc., CSL Limited, Grifols, S.A., and Octapharma Inc.

Table of Content

1. Market Overview
1.1 Blood Plasma 
1.2 Blood Plasma Derivatives 
1.3 Functions of Blood Plasma 
1.4 Plasma Collection
 
2. Global Market Analysis

2.1 Global Blood Plasma Market Forecast by Value 
2.2 Global Blood Plasma Fractionation Capacity Forecast
2.3 Global Blood Plasma Market by Region
2.4 Global Blood Plasma Market by Segment 
2.5 Global Immunoglobulin Market 
2.5.1 Global Immunoglobulin Market Forecast by Value 
2.5.2 Global Immunoglobulin Market Forecast by Volume
2.5.3 Global Immunoglobulin Market Volume by Region
2.5.4 Global Immunoglobulin Market by Types 
2.5.5 Global Immunoglobulin Population by Indication 
2.6 Global Albumin Market 
2.6.1 Global Albumin Market Forecast by Value 
2.6.2 Global Albumin Market Forecast by Volume 
2.6.3 Global Albumin Market Volume by Region 
2.7 Global Factor VIII Market 
2.7.1 Global Factor VIII Market Forecast by Value 
2.7.2 Global Factor VIII Market Forecast by Volume
2.7.3 Global Factor VIII Market by Type
 
3. Regional Analysis
3.1 The US
3.1.1 The US Blood Plasma Market by Segments 
3.1.2 The US Immunoglobulin Market Forecast by Value
3.1.3 The US Immunoglobulin Market Forecast by Volume 
3.1.4 The US Immunoglobulin Market Volume by Segment 
3.1.5 The US Immunoglobulin Market by Specialty
3.1.6 The US Albumin Market Forecast by Volume
3.2 China 
3.2.1 China’s Blood Plasma Market Forecast by Value 
3.2.2 China’s Blood Plasma Market by Segments 
3.2.3 China’s Albumin Market Forecast by Value 
3.2.4 China’s Immunoglobulin Market Forecast by Value 
3.2.5 China’s Factor VIII Market Forecast by Value
 
4. Market Dynamics
4.1 Trends & Developments 
4.1.1 Increasing Fractionation Capacity 
4.1.2 Growing AATD Market Potential 
4.1.3 Innovation in Therapeutics Via Existing and New Proteins
4.2 Growth Drivers 
4.2.1 Increased Diagnosis of Disease Treated by Immunoglobulin 
4.2.2 Increasing Plasma Collection 
4.2.3 Growing Blood Plasma Market in Emerging Economies 
4.2.4 Popularity of Albumin in Asian Countries 
4.2.5 Increasing Healthcare Expenditure 
4.2.6 Escalating Ageing Population
4.3 Challenges & Issues 
4.3.1 High Cost of Treatment 
4.3.2 Unclear & Lengthy Process to Open Plasma Centre 
4.3.3 High R&D Costs
 
5. Competitive Landscape
5.1 Global Market 
5.1.1 Global Blood Plasma Market Share 
5.1.2 Global Immunoglobulin Market Share 
5.1.3 Global Albumin Market Share 
5.1.4 Global Plasma-Derived Factor VIII Market Share 
5.1.5 Global Alpha1 Market Share 
5.1.6 Global Blood Plasma Centers by Major Players
 
6. Company Profiles
6.1 Shire Plc. 
6.1.1 Business Overview 
6.1.2 Financial Overview 
6.1.3 Business Strategies
6.2 CSL Limited
6.2.1 Business Overview 
6.2.2 Financial Overview 
6.2.3 Business Strategies
6.3 Grifols, S.A. 
6.3.1 Business Overview 
6.3.2 Financial Overview 
6.3.3 Business Strategies
6.4 Octapharma, Inc. 
6.4.1 Business Overview 
6.4.2 Financial Overview 
6.4.3 Business Strategies

Blood Plasma Protein Breakup 
Functions of Blood Plasma 
Fractionation Capacity of Key Market Players (2013-2022E)
Therapeutic Products Under Development (2016)
Shire PLC’s Major Product Approvals & Launches (2016) 
Shire PLC’s Major Product Pipeline (2016) 
CSL Ltd.’s Major Product Development (2016)

Components of Blood Plasma 
Global Blood Plasma Market Forecast by Value (2016-2021)
Global Blood Plasma Fractionation Capacity Forecast (2016-2021)
Global Blood Plasma Market by Region (2016)
Global Blood Plasma Market by Segment (2016)
Global Immunoglobulin Market Forecast by Value (2016-2021)
Global Immunoglobulin Market Forecast by Volume (2016-2021)
Global Immunoglobulin Market Volume by Region (2016)
Global Immunoglobulin Market by Types (2016) 
Global Immunoglobulin Population by Indication (2016)
Global Albumin Market Forecast by Value (2016-2021) 
Global Albumin Market Forecast by Volume (2016-2021)
Global Albumin Market Volume by Region (2016) 
Global Factor VIII Market Forecast by Value (2016-2021) 
Global Factor VIII Market Forecast by Volume (2016-2021)
Global Factor VIII Market by Type (2016)
The US Blood Plasma Market by Segment (2016) 
The US Immunoglobulin Market Forecast by Value (2016-2021)
The US Immunoglobulin Market Forecast by Volume (2016-2021)
The US Immunoglobulin Market Volume by Segment (2016)
The US Immunoglobulin Market by Specialty (2016)
The US Albumin Market Forecast by Volume (2016-2021) 
China’s Blood Plasma Market Forecast by Value (2016-2021) 
China’s Blood Plasma Market by Segments (2016)
China’s Albumin Market Forecast by Value (2016-2021)
China’s Immunoglobulin Market Forecast by Value (2016-2021)
China’s Factor VIII Market Forecast by Value (2016-2021)
Global Alpha1 Patient Population (2016)
The US CIDP Market Opportunity (2016) 
Plasma Collection in the US (2012-2016)
Albumin Consumption Per Capita by Country (2016)
Global Healthcare Expenditure (2012-2016) 
Global Ageing Population of 60 Years or Older (2000-2030E)
Global Blood Plasma Market Share by Company (2016)
Global Immunoglobulin Market Share by Company (2016) 
Global Albumin Market Share by Company (2016)
Global Plasma-Derived Factor VIII Market Share by Company (2016) 
Global Alpha1 Market Share by Company (2016)
Global Blood Plasma Centers by Major Players (2016)
Shire Plc. Revenue Share by Franchise (2016) 
Shire PLC’s Revenue and Net Income (2012-2016) 
CSL Limited’s Revenue Share by Products (2016) 
CSL Limited’s Revenue and Net Profit (2012-2016)
Research & Development Investments of CSL Limited (2012-2016)
Grifols, S.A. Revenue Share by Business Segments (2016) 
Grifols, S.A. Revenue and Gross Profit (2012-2016)
Octapharma, Inc. Revenue (2012-2016)